Ken Griffin Masimo Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$115.24 - $144.91 $749,060 - $941,915	-6,500 Reduced 20.5%	25,200 $3.17 Million
Q1 2024 May 15, 2024	SELL	$109.17 - $146.85 $21.8 Million - $29.3 Million	-199,400 Reduced 86.28%	31,700 $4.66 Million
Q4 2023 Feb 14, 2024	SELL	$76.73 - $120.62 $25.9 Million - $40.8 Million	-338,100 Reduced 59.4%	231,100 $27.1 Million
Q3 2023 Nov 14, 2023	BUY	$84.17 - $161.17 $45.7 Million - $87.6 Million	543,400 Added 2106.2%	569,200 $49.9 Million
Q2 2023 Aug 14, 2023	SELL	$155.24 - $196.47 $1.85 Million - $2.34 Million	-11,900 Reduced 31.56%	25,800 $4.25 Million
Q1 2023 May 15, 2023	BUY	$146.03 - $184.54 $1.77 Million - $2.23 Million	12,100 Added 47.27%	37,700 $6.96 Million
Q4 2022 Feb 14, 2023	BUY	$110.88 - $150.36 $1.9 Million - $2.57 Million	17,100 Added 201.18%	25,600 $3.79 Million
Q3 2022 Nov 14, 2022	SELL	$125.58 - $169.38 $175,812 - $237,132	-1,400 Reduced 14.14%	8,500 $1.2 Million

388

42.8M

277K

348K

Ticker MASI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 52,530,200
Market Cap $8.45B
Description
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.